- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for AstraZeneca PLC (AZN)
| Open: | 41.0200 | Day's Range: | 41.0200 - 41.3600 | Volume: | 770,432 | Bid: | 41.2400 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 41.1800 | 52wk Range: | 40.7600 - 52.5400 | 1-Yr Rtn: | -15.57% | Ask: | 41.2500 |
Key Statistics for AZN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | 7.0539 |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2012) | 5.8450 |
| Est. PEG Ratio | 3.6931 |
| Market Cap (M USD) | 52,133.76 |
| Shares Outstanding (M) | 1,264.46 |
| Enterprise Value (M USD) (ttm) | - |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 9.4568 |
| Next Earnings Announcement | 07/26/2012 |
More AZN Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for AZN
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for AZN
AstraZeneca PLC is a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia, and Infection.
| Louis SchweitzerChairman | David Richard BrennanCEO/Executive Director |
| Simon Jonathan LowthCFO/Executive Director | Katarina AgeborgChief Compliance Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page